Today’s top gainers include the company CR Bard Inc. (NYSE:BCR) which is in the industry Medical Instruments & Supplies, gaining -1.04% today. In the last week its performance is -0.62%, and -2.24% for the past quarter. Currently, CR Bard Inc., BCR has a target price of 243.83, so today’s gain of -1.04% is a significant step towards its target price. The GAP today is therefore -0.29%.
CR Bard Inc. (NYSE:BCR), has a market cap of 16161.14, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 90.50%.
At the current price of 219.73, it has a dividend yield of 0.47%, and its target price is 243.83. This is with a profit margin of 9.10%, and total debt/equity of 1.01. CR Bard Inc. (NYSE:BCR) has a P/E of 43.4, as well as a forward P/E of 19.45.
With a current EPS of 5.06, and a forecasted EPS growth for next year at 11.14%,CR Bard Inc. (NYSE:BCR) has had a EPS growth for the past five years at -19.80%. For the next five years EPS growth is projected to be 10.87%.
Performance for the year is 14.58%. Since its IPO date on 4/6/1983, the total performance to date is 16.41%.
Volume today for CR Bard Inc. (NYSE:BCR), is 350900, while its average volume is 434.61. Whilst the total gain today was -1.04%, it did have a day high of -8.13%.
Volatility for this week has been at 1.09%, and 1.10% for the month. The 52-week low for CR Bard Inc., BCR has been 28.06%, while the 52-week-high has reached -8.13%.
Looking at its return of investments, which is 6.40%, and its return on assets is 6.30%. CR Bard Inc. (NYSE:BCR) has an operating margin of 14.10%. With a sales growth of -44.50% quarter over quarter. Bearing in mind that CR Bard Inc., BCR is in the sector Healthcare, its long-term debt/equity is 1.01, and has a current ratio of 2.4 and 1.9 for quick ratio.
So what is the value of CR Bard Inc.? Well its PEG is 3.99, and the P/S is 4.56, along with a P/B of 9.99. Meanwhile it has a p/cash of 20.26.